icon3

Regenerative Medicine Market By Type (Cell-Based Products & Acellular Products) By Therapy (Cell Therapy, Gene Therapy, Others) By Application (Orthopedic & Musculoskeletal Disorders, Cardiology, Others) Regional Analysis & Forecast - 2026

  • OI-85
  • |
  • Published date: Mar, 2019
  • |
  • Life Sciences & Healthcare
  • |
  • Pages

Regenerative medicine is one of the branches of medicine, which works by re-growing and repairing the damaged cells in the human body. These medicines include the use of stem cells, gene therapies, tissue engineering, which helps further in developing new organ that will function smoothly. These medicines have the capability of developing an entire organ because these are multipotent cells. The cells are mainly isolated from bone marrow, and umbilical cord blood and applied to treat the diseases like oncology, neurodegenerative, orthopedic, cardiovascular, dermatology, ocular, wound healing and genetic diseases.

Market Overview


The leading players in the market will emphasize on innovations and the development of new drugs and treatments, which will support the market growth in the coming few years. The key factors propelling the global regenerative medicine market growth include the increase in adoption of stem cell technologies, tissue engineering, and gene therapies, and the technological advancements in regenerative medicine.


The recent advancements in regenerative medicine include the regenerated tracheas for transplant, stem cell treatments for vision loss, 3D bioprinting, and stem cell treatments for heart repair. The current market is witnessing large-scale R&D activities. Besides the R&D activities being conducted by private players, there is significant involvement of academic institutions for conducting various researches. Thus, in the near future, several new biotech and medtech companies are expected to start up, as the result of the current R&D attempts across the world.


The regenerative medicine market is driven by the increase in the number of individuals suffering from cancer, the rise in need to monitor and treat these chronic diseases in a limited period. Further, stringent government policies, increasing government healthcare expenditure for developing healthcare infrastructure and proper reimbursement policies are going to boost the market growth in the coming years. Additionally, the rise in the number of organ transplantation, and an increase in the number of products in the pipeline that are waiting for approval create a great opportunity for the regenerative medicines in the coming years. Anyway, lack of proper regulatory for the approval of various drugs, and some of the ethical and religious concerns for the using stem cells would impede the market growth during the forecast period.

Key Developments



  • As reported in Alliance for Regenerative Medicine (ARM) 2018 Annual Data Report, companies active in cell therapies and gene therapies have increased more than $13.3 billion in 2018. In Europe, the sector raised to nearly 40% when compared to the previous year.

  • In February 2016, Acelity (U.S.) had partnered with Mediq (Netherlands), leading home care and medical device Delivery Company. Under the agreement terms, Mediq will distribute Acelity’s advanced wound care and regenerative medicine portfolio in Denmark, Finland, Norway, and Sweden.


Segmentation


The global Regenerative medicine market is segmented as follows:


By Type: Cell-based products, Acellular products. The cell-based products dominated the growth of the global market.


By Therapy: Cell Therapy, Gene Therapy, Tissue Engineering, and Immunotherapy. Immunotherapy accounted for the fastest growing segment in the global market, during the forecast period.


By Application: Orthopedic & Musculoskeletal Disorders, Cardiology, Dermatology, Diabetes, Central Nervous System Diseases, and Other Applications (ocular, autoimmune, dental/oral, and rare diseases). Oncology accounted for the fastest growing application market in the global market. Dermatology is estimated to have the largest share in revenue generation, and this high contribution is attributive to the presence of easy grafting techniques for dermatological wounds and diseases.

By Region: North America, Europe, Asia-Pacific regions.


North America holds the highest revenue in the Regenerative Medicine market and is expected to lead the region globally during the forecast period. The Asia Pacific is expected to be the fastest growing region in the coming years. The growth in this region is mainly attributed to the development of healthcare infrastructure of the countries like India, & China, and rise in awareness of using the regenerative medicines as an effective treatment to treat chronic diseases.

The key players involved in the development of growth of Regenerative Medicine market include Organogenesis Inc., Vericel Corporation, Osiris Therapeutics, Inc., Stryker Corporation, and NuVasive, Inc., Medtronic Plc., Acelity, Cook Biotech Inc., Integra LifeSciences, and C.R. Bard.



 

 

 

Report Description: The report covers in-depth analysis of Regenerative Medicine Market. The report assesses the Regenerative Medicine pipeline by stage of development (early development, pre-clinical, clinical and in approval), by application (Oncology, neurodegenerative, orthopedic, cardiovascular, dermatology, and others). In addition, the report includes key insights on other development activities, including (but not limited to) – licensing (In and Out), collaborations, acquisitions, reimbursement, patent, and regulatory designations

The report includes in-depth company profiles of key players in Regenerative Medicine Market. The company profile includes key information on the overview, financial highlights, product portfolio, business strategies, and key recent developments


The report highlights information on emerging companies with potentially disruptive technologies and new market entrants


Scope:



  • Provides detailed analysis of the market structure along with forecast of the various segments and sub-segments of the Regenerative Medicine

  • Provides a comparative analysis of key marketed products and pipeline Regenerative Medicines.

  • Provides key information on players involved in the Regenerative Medicine

  • Provides a complete overview of market segments and the regional outlook of Regenerative Medicine

  • Provides in-depth coverage of key news related to Regenerative Medicine Market, including major mergers and acquisitions and product development updates such as clinical trial progression updates and regulatory updates.

Our research works on a holistic 360° approach to deliver high quality, validated and reliable information in our market reports. Market estimation and forecasting involve the following steps:




  • Data Collation (Primary & Secondary)




  • In-house Estimation (Based on proprietary databases and Models)




  • Market Triangulation




  • Forecasting




  • Market-related information is assembled from both primary and secondary sources. 








  • Primary sources involved participants from all global stakeholders such as experts from several related industries and suppliers that have been interviewed to obtain and verify critical information as well as to assess prospects of the market. The participants included are CXOs, VPs, and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services. 








  • Secondary sources include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications annual reports press releases along with paid sources such as Factiva, OneSource, Bloomberg among others. 








  • Top-down and bottom-up approaches: The overall market size was used in the top-down approach to estimate the sizes of other individual submarkets (mentioned in the market segmentation by product, type of manufacturing, and disease) through percentage splits from secondary and primary research. The bottom-up approach was also implemented (wherever applicable) for data extracted from secondary research to validate the market segment revenues obtained.





REPORT YOU MIGHT BE INTERESTED

Choose Licence Type

$3,850.00
$4,950.00


(For Corporate Licence Only) Complementary
Credit card Logo
Inquiry Before Buying

Related Reports


Contact Us

Email Us at: sales@optimainsights.org | Reach Us at: +91 966 6620 365 | +1 424 2554 365 (US)